The DOI matches its Crossref record; 428 of the 428 references it cites were found in a registry or an index.
Pathophysiology and Pharmacological Treatment of Insulin Resistance*
Open accessAbstract
Diabetes mellitus type 2 is a world-wide growing health problem affecting more than 150 million people at the beginning of the new millennium. It is believed that this number will double in the next 25 yr. The pathophysiological hallmarks of type 2 diabetes mellitus consist of insulin resistance, pancreatic β-cell dysfunction, and increased endogenous glucose production. To reduce the marked increase of cardiovascular mortality of type 2 diabetic subjects, optimal treatment aims at normalization of body weight, glycemia, blood pressure, and lipidemia. This review focuses on the pathophysiology and molecular pathogenesis of insulin resistance and on the capability of antihyperglycemic pharmacological agents to treat insulin resistance, i.e., α-glucosidase inhibitors, biguanides, thiazolidinediones, sulfonylureas, and insulin. Finally, a rational treatment approach is proposed based on the dynamic pathophysiological abnormalities of this highly heterogeneous and progressive disease.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Positional cloning of the mouse obese gene and its human homologue
Zhang, Y., Proenca, R., Maffei, M., Barone, M., Leopold, L., & Friedman, J. M. (1994) · Nature · doi:10.1038/372425a0 · Cited by 13,419
Glucose clamp technique: a method for quantifying insulin secretion and resistance.
DeFronzo, R. A., Tobin, J. D., & Andres, R. (1979) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.1979.237.3.e214 · Cited by 7,425
Epstein, F. H., Steinberg, D., Parthasarathy, S., Carew, T. E., Khoo, J. C., & Witztum, J. L. (1989) · New England Journal of Medicine · doi:10.1056/nejm198904063201407 · Cited by 6,427
Leptin and the regulation of body weight in mammals
Friedman, J. M., & Halaas, J. L. (1998) · Nature · doi:10.1038/27376 · Cited by 5,405
Randle, P. J., Garland, P. B., Hales, C. N., & Newsholme, E. A. (1963) · The Lancet · doi:10.1016/s0140-6736(63)91500-9 · Cited by 5,093
Stearne, M. R., Palmer, S. L., Hammersley, M. S., Franklin, S. L., Spivey, R. S., Lévy, J., Tidy, C. R., Bell, N. J., Steemson, J., Barrow, B. A., et al. (1998) · UCL Discovery (University College London) · Cited by 4,802
Pan, X.-R., Li, G.-W., Hu, Y.-H., Wang, J.-X., Yang, W.-Y., An, Z.-X., Hu, Z.-X., Juan-Lin, Xiao, J.-Z., Cao, H.-B., et al. (1997) · Diabetes Care · doi:10.2337/diacare.20.4.537 · Cited by 4,320
Mechanisms of fatty acid-induced inhibition of glucose uptake.
Boden, G., Chen, X., Ruiz, J., White, J. V., & Rossetti, L. (1994) · Journal of Clinical Investigation · doi:10.1172/jci117252 · Cited by 3,705
Hotamisligil, G. S., Arner, P., Caro, J. F., Atkinson, R. L., & Spiegelman, B. M. (1995) · Journal of Clinical Investigation · doi:10.1172/jci117936 · Cited by 3,543
Stimulation of adipogenesis in fibroblasts by PPARγ2, a lipid-activated transcription factor
Tontonoz, P., Hu, E., & Spiegelman, B. M. (1994) · Cell · doi:10.1016/0092-8674(94)90006-x · Cited by 3,529
The peroxisome proliferator-activated receptor-γ is a negative regulator of macrophage activation
Ricote, M., Li, A. C., Willson, T. M., Kelly, C. J., & Glass, C. K. (1998) · Nature · doi:10.1038/34178 · Cited by 3,525
Identification and expression cloning of a leptin receptor, OB-R.
Tartaglia, L. A., Dembski, M., Weng, X., Deng, N., Culpepper, J., Devos, R., Richards, G. J., Campfield, L. A., Clark, F. T., Deeds, J., et al. (1995) · Cell · doi:10.1016/0092-8674(95)90151-5 · Cited by 3,496
Congenital leptin deficiency is associated with severe early-onset obesity in humans
Montague, C. T., Farooqi, I. S., Whitehead, J. P., Soos, M. A., Rau, H., Wareham, N. J., Sewter, C. P., Digby, J. E., Mohammed, S. N., Hurst, J. A., et al. (1997) · Nature · doi:10.1038/43185 · Cited by 2,936
Alessi, D. R., James, S. R., Downes, C. P., Holmes, A. B., Gaffney, P. R. J., Reese, C. B., & Cohen, P. (1997) · Current Biology · doi:10.1016/s0960-9822(06)00122-9 · Cited by 2,826
Hotamisligil, G. S., Peraldi, P., Budavari, A., Ellis, R., White, M. F., & Spiegelman, B. M. (1996) · Science · doi:10.1126/science.271.5249.665 · Cited by 2,630
The Triumvirate: β-Cell, Muscle, Liver: A Collusion Responsible for NIDDM
DeFronzo, R. A. (1988) · Diabetes · doi:10.2337/diab.37.6.667 · Cited by 2,456
A mutation in the human leptin receptor gene causes obesity and pituitary dysfunction
Clément, K., Vaisse, C., Lahlou, N., Cabrol, S., Pelloux, V., Cassuto, D., Gourmelen, M., Dina, C., Chambaz, J., Lacorte, J.-M., et al. (1998) · Nature · doi:10.1038/32911 · Cited by 2,346
Chen, H., Charlat, O., Tartaglia, L. A., Woolf, E. A., Weng, X., Ellis, S. J., Lakey, N. D., Culpepper, J., More, K. J., Breitbart, R. E., et al. (1996) · Cell · doi:10.1016/s0092-8674(00)81294-5 · Cited by 2,214
Pathogenesis of NIDDM. A balanced overview.
DeFronzo, R. A., Bonadonna, R. C., & Ferrannini, E. (1992) · Diabetes Care · doi:10.2337/diacare.15.3.318 · Cited by 2,085
Oxidized LDL Regulates Macrophage Gene Expression through Ligand Activation of PPARγ
Nagy, L., Tontonoz, P., Alvarez, J. G. A., Chen, H., & Evans, R. M. (1998) · Cell · doi:10.1016/s0092-8674(00)81574-3 · Cited by 1,860
PPARγ Promotes Monocyte/Macrophage Differentiation and Uptake of Oxidized LDL
Tontonoz, P., Nagy, L., Alvarez, J. G. A., Thomazy, V. A., & Evans, R. M. (1998) · Cell · doi:10.1016/s0092-8674(00)81575-5 · Cited by 1,797
Disruption of IRS-2 causes type 2 diabetes in mice
Withers, D. J., Gutierrez, J. S., Towery, H., Burks, D. J., Ren, J.-M., Previs, S., Zhang, Y., Bernal, D., Pons, S., Shulman, G. I., et al. (1998) · Nature · doi:10.1038/36116 · Cited by 1,775
Ward, A., & Clissold, S. P. (1987) · Drugs · doi:10.2165/00003495-198734010-00003 · Cited by 1,754
PPAR-gamma: adipogenic regulator and thiazolidinedione receptor.
Spiegelman, B. M. (1998) · Diabetes · doi:10.2337/diabetes.47.4.507 · Cited by 1,730
Role of Fatty Acids in the Pathogenesis of Insulin Resistance and NIDDM
Boden, G. (1997) · Diabetes · doi:10.2337/diab.46.1.3 · Cited by 1,728
Bailey, C. J., & Turner, R. C. (1996) · New England Journal of Medicine · doi:10.1056/nejm199602293340906 · Cited by 1,726
Pyörälä, K., Pedersen, T. R., Kjekshus, J., Faergeman, O., Olsson, A. G., Thorgeirsson, G., & The Scandinavian Simvastatin Survival Study (4S) Group (1997) · Diabetes Care · doi:10.2337/diacare.20.4.614 · Cited by 1,623
Structure of the insulin receptor substrate IRS-1 defines a unique signal transduction protein
Sun, X. J., Rothenberg, P., Kahn, C. R., Backer, J. M., Araki, E., Wilden, P. A., Cahill, D. A., Goldstein, B. J., & White, M. F. (1991) · Nature · doi:10.1038/352073a0 · Cited by 1,574
Stearne, M. R., Palmer, S. L., Hammersley, M. S., Franklin, S. L., Spivey, R. S., Lévy, J., Tidy, C. R., Bell, N. J., Steemson, J., Barrow, B. A., et al. (1998) · UCL Discovery (University College London) · Cited by 1,406
Efficacy of Metformin in Patients with Non-Insulin-Dependent Diabetes Mellitus
DeFronzo, R. A., & Goodman, A. M. (1995) · New England Journal of Medicine · doi:10.1056/nejm199508313330902 · Cited by 1,368
Deeb, S. S., Fajas, L., Nemoto, M., Pihlajamäki, J., Mykkänen, L., Kuusisto, J., Laakso, M., Fujimoto, W., & Auwerx, J. (1998) · Nature Genetics · doi:10.1038/3099 · Cited by 1,319
Alternative pathway of insulin signalling in mice with targeted disruption of the IRS-1 gene
Araki, E., Lipes, M. A., Patti, M.-E., Brüning, J. C., Haag III, B., Johnson, R. S., & Kahn, C. R. (1994) · Nature · doi:10.1038/372186a0 · Cited by 1,252
Metabolic effects of metformin in non-insulin-dependent diabetes mellitus
Stumvoll, M., Nurjhan, N., Perriello, G., Dailey, G., & Gerich, J. E. (1995) · New England Journal of Medicine · doi:10.1056/nejm199508313330903 · Cited by 1,148
Insulin Stimulates the Phosphorylation of the 95,000-Dalton Subunit of Its Own Receptor
Kasuga, M., Karlsson, F. A., & Kahn, C. R. (1982) · Science · doi:10.1126/science.7031900 · Cited by 1,126
Protein Kinase C Isotypes Controlled by Phosphoinositide 3-Kinase Through the Protein Kinase PDK1
Le Good, J. A., Ziegler, W. H., Parekh, D. B., Alessi, D. R., Cohen, P., & Parker, P. J. (1998) · Science · doi:10.1126/science.281.5385.2042 · Cited by 1,110
Insulin resistance and growth retardation in mice lacking insulin receptor substrate-1
Tamemoto, H., Kadowaki, T., Tobe, K., Yagi, T., Sakura, H., Hayakawa, T., Terauchi, Y., Ueki, K., Kaburagi, Y., Satoh, S., et al. (1994) · Nature · doi:10.1038/372182a0 · Cited by 1,083
Exercise, Glucose Transport, and Insulin Sensitivity
Goodyear, L. J., & Kahn, B. B. (1998) · Annual Review of Medicine · doi:10.1146/annurev.med.49.1.235 · Cited by 1,056
Differentiation and reversal of malignant changes in colon cancer through PPARγ
Sarraf, P., Mueller, E., Jones, D., King, F. J., DeAngelo, D. J., Partridge, J. B., Holden, S. A., Chen, L. B., Singer, S., Fletcher, C., et al. (1998) · Nature Medicine · doi:10.1038/2030 · Cited by 988
Phosphoinositide 3-kinase: the key switch mechanism in insulin signalling
SHEPHERD, P. R., WITHERS, D. J., & SIDDLE, K. (1998) · Biochemical Journal · doi:10.1042/bj3330471 · Cited by 953
Improvement in Glucose Tolerance and Insulin Resistance in Obese Subjects Treated with Troglitazone
Nolan, J. J., Ludvik, B., Beerdsen, P., Joyce, M., & Olefsky, J. (1994) · New England Journal of Medicine · doi:10.1056/nejm199411033311803 · Cited by 926
Insulin Action, Diabetogenes, and the Cause of Type II Diabetes
Kahn, C. R. (1994) · Diabetes · doi:10.2337/diab.43.8.1066 · Cited by 916
Role of IRS-2 in insulin and cytokine signalling
Sun, X. J., Wang, L.-M., Zhang, Y., Yenush, L., Myers Jr, M. G., Glasheen, E., Lane, W. S., Pierce, J. H., & White, M. F. (1995) · Nature · doi:10.1038/377173a0 · Cited by 848
Groop, L. C., Bonadonna, R. C., DelPrato, S., Ratheiser, K., Zyck, K., Ferrannini, E., & DeFronzo, R. A. (1989) · Journal of Clinical Investigation · doi:10.1172/jci114142 · Cited by 812 · cited 3×
“In obese subjects and patients with type 2 diabetes the EC50 values are increased 2- to 3-fold (44, 47, 49), indicating that adipose tissue lipolysis is at least as resistant to the action of insulin as muscle and liver.”
BackgroundInsulin Resistance — Mechanisms, Syndromes, and Implications
Epstein, F. H., Moller, D. E., & Flier, J. S. (1991) · New England Journal of Medicine · doi:10.1056/nejm199109263251307 · Cited by 801
Efficacy and Metabolic Effects of Metformin and Troglitazone in Type II Diabetes Mellitus
Inzucchi, S. E., Maggs, D. G., Spollett, G. R., Page, S. L., Rife, F. S., Walton, V., & Shulman, G. I. (1998) · New England Journal of Medicine · doi:10.1056/nejm199803263381303 · Cited by 794
Nestler, J. E., Jakubowicz, D. J., Evans, W. S., & Pasquali, R. (1998) · New England Journal of Medicine · doi:10.1056/nejm199806253382603 · Cited by 784
Rossetti, L., Giaccari, A., & DeFronzo, R. A. (1990) · Diabetes Care · doi:10.2337/diacare.13.6.610 · Cited by 770
(1999) · Diabetes Care · doi:10.2337/diacare.22.4.623 · Cited by 725
Modulation of Insulin Activities by Leptin
Cohen, B., Novick, D., & Rubinstein, M. (1996) · Science · doi:10.1126/science.274.5290.1185 · Cited by 716
Perseghin, G., Price, T. B., Petersen, K. F., Roden, M., Cline, G. W., Gerow, K., Rothman, D. L., & Shulman, G. I. (1996) · New England Journal of Medicine · doi:10.1056/nejm199610313351804 · Cited by 699
PKB/Akt: connecting phosphoinositide 3-kinase to cell survival and beyond
Marte, B. (1997) · Trends in Biochemical Sciences · doi:10.1016/s0968-0004(97)01097-9 · Cited by 689
Moghetti, P., Castello, R., Negri, C., Tosi, F., Perrone, F., Caputo, M., Zanolin, E., & Muggeo, M. (2000) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.85.1.6293 · Cited by 660
Insulin rapidly stimulates tyrosine phosphorylation of a Mr-185,000 protein in intact cells
White, M. F., Maron, R., & Kahn, C. R. (1985) · Nature · doi:10.1038/318183a0 · Cited by 651
Sympathetic Activation in Obese Normotensive Subjects
Grassi, G., Seravalle, G., Cattaneo, B. M., Bolla, G. B., Lanfranchi, A., Colombo, M., Giannattasio, C., Brunani, A., Cavagnini, F., & Mancia, G. (1995) · Hypertension · doi:10.1161/01.hyp.25.4.560 · Cited by 614
PPARγ, the ultimate thrifty gene
Auwerx, J. (1999) · Diabetologia · doi:10.1007/s001250051268 · Cited by 612
Lefebvre, A.-M., Chen, I., Desreumaux, P., Najib, J., Fruchart, J.-C., Geboes, K., Briggs, M., Heyman, R., & Auwerx, J. (1998) · Nature Medicine · doi:10.1038/2036 · Cited by 611
Regulation of protein kinase C ζ by PI 3-kinase and PDK-1
Chou, M. M., Hou, W., Johnson, J., Graham, L. K., Lee, M. H., Chen, C.-S., Newton, A. C., Schaffhausen, B. S., & Toker, A. (1998) · Current Biology · doi:10.1016/s0960-9822(98)70444-0 · Cited by 608
Mitrakou, A., Kelley, D., Mokan, M., Veneman, T., Pangburn, T., Reilly, J., & Gerich, J. (1992) · New England Journal of Medicine · doi:10.1056/nejm199201023260104 · Cited by 595
Bailey, C. J. (1992) · Diabetes Care · doi:10.2337/diacare.15.6.755 · Cited by 593
Hanis, C. L., Boerwinkle, E., Chakraborty, R., Ellsworth, D. L., Concannon, P., Stirling, B., Morrison, V. A., Wapelhorst, B., Spielman, R. S., Gogolin-Ewens, K. J., et al. (1996) · Nature Genetics · doi:10.1038/ng0696-161 · Cited by 590
Activators of the nuclear receptor PPARγ enhance colon polyp formation
Saez, E., Tontonoz, P., Nelson, M. C., Alvarez, J. G. A., U, T. M., Baird, S. M., Thomazy, V. A., & Evans, R. M. (1998) · Nature Medicine · doi:10.1038/2042 · Cited by 587
Lebovitz, H. E. (1997) · Endocrinology and Metabolism Clinics of North America · doi:10.1016/s0889-8529(05)70266-8 · Cited by 563
Finegood, D. T., Bergman, R. N., & Vranic, M. (1987) · Diabetes · doi:10.2337/diab.36.8.914 · Cited by 546
DeFronzo, R. A., Simonson, D., & Ferrannini, E. (1982) · Diabetologia · doi:10.1007/bf00253736 · Cited by 541
Goodyear, L. J., Giorgino, F., Sherman, L. A., Carey, J., Smith, R. J., & Dohm, G. L. (1995) · Journal of Clinical Investigation · doi:10.1172/jci117909 · Cited by 526
Dunaif, A., Scott, D., Finegood, D., Quintana, B., & Whitcomb, R. (1996) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.81.9.8784087 · Cited by 524
Ofei, F., Hurel, S., Newkirk, J., Sopwith, M., & Taylor, R. (1996) · Diabetes · doi:10.2337/diab.45.7.881 · Cited by 510
Yen, C.-J., Beamer, B. A., Negri, C., Silver, K., Brown, K. A., Yarnall, D. P., Burns, D. K., Roth, J., & Shuldiner, A. R. (1997) · Biochemical and Biophysical Research Communications · doi:10.1006/bbrc.1997.7798 · Cited by 491
Peroxisome proliterator-activated receptors, orphans with ligands and functions
Schoonjans, K., Martin, G., Staels, B., & Auwerx, J. (1997) · Current Opinion in Lipidology · doi:10.1097/00041433-199706000-00006 · Cited by 489
The Effect of Insulin Treatment on Insulin Secretion and Insulin Action in Type II Diabetes Mellitus
Garvey, W. T., Olefsky, J. M., Griffin, J., Hamman, R. F., & Kolterman, O. G. (1985) · Diabetes · doi:10.2337/diab.34.3.222 · Cited by 488
Kim, Y.-B., Nikoulina, S. E., Ciaraldi, T. P., Henry, R. R., & Kahn, B. B. (1999) · Journal of Clinical Investigation · doi:10.1172/jci6928 · Cited by 487
Long-term Effects of Modest Weight Loss in Type II Diabetic Patients
Wing, R. R. (1987) · Archives of Internal Medicine · doi:10.1001/archinte.1987.00370100063012 · Cited by 484
Hanson, R. L., Ehm, M. G., Pettitt, D. J., Prochazka, M., Thompson, D. B., Timberlake, D., Foroud, T., Kobes, S., Baier, L., Burns, D. K., et al. (1998) · The American Journal of Human Genetics · doi:10.1086/302061 · Cited by 475
?-Glucosidase inhibitors: New complex oligosaccharides of microbial origin
Schmidt, D. D., Frommer, W., Junge, B., M�ller, L., Wingender, W., Truscheit, E., & Sch�fer, D. (1977) · Naturwissenschaften · doi:10.1007/bf00483561 · Cited by 467
Discovery of a Small Molecule Insulin Mimetic with Antidiabetic Activity in Mice
Zhang, B., Salituro, G., Szalkowski, D., Li, Z., Zhang, Y., Royo, I., Vilella, D., Dı́ez, M. T., Pelaez, F., Ruby, C., et al. (1999) · Science · doi:10.1126/science.284.5416.974 · Cited by 456
Cusi, K. (1996) · Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.81.11.4059 · Cited by 455
Unger, R. H., & Grundy, S. (1985) · Diabetologia · doi:10.1007/bf00273856 · Cited by 452
Ferrannini, E. (1998) · Endocrine Reviews · doi:10.1210/edrv.19.4.0336 · Cited by 451
Leptin Impairs Metabolic Actions of Insulin in Isolated Rat Adipocytes
Müller, G., Ertl, J., Gerl, M., & Preibisch, G. (1997) · Journal of Biological Chemistry · doi:10.1074/jbc.272.16.10585 · Cited by 450
Holman, R. R., Cull, C. A., & Turner, R. C. (1999) · Diabetes Care · doi:10.2337/diacare.22.6.960 · Cited by 449
Hepatic Dysfunction Associated with Troglitazone
Watkins, P. B., & Whitcomb, R. W. (1998) · New England Journal of Medicine · doi:10.1056/nejm199803263381314 · Cited by 446
The Disposal of an Oral Glucose Load in Healthy Subjects: A Quantitative Study
Ferrannini, E., Bjorkman, O., Reichard, G. A., Pilo, A., Olsson, M., Wahren, J., & DeFronzo, R. A. (1985) · Diabetes · doi:10.2337/diab.34.6.580 · Cited by 439
Standaert, M. L., Galloway, L., Karnam, P., Bandyopadhyay, G., Moscat, J., & Farese, R. V. (1997) · Journal of Biological Chemistry · doi:10.1074/jbc.272.48.30075 · Cited by 436
Chiasson, J.-L., Josse, R. G., Hunt, J. A., Palmason, C., Rodger, N. W., Ross, S. A., Ryan, E. A., Tan, M. H., & Wolever*, T. M. S. (1994) · Annals of Internal Medicine · doi:10.7326/0003-4819-121-12-199412150-00004 · Cited by 436
Yki-Järvinen, H., Ryysy, L., Nikkilä, K., Tulokas, T., Vanamo, R., & Heikkilä, M. (1999) · Annals of Internal Medicine · doi:10.7326/0003-4819-130-5-199903020-00002 · Cited by 433
Pathogenesis of Type 2 (non-insulin dependent) diabetes mellitus: a balanced overview
DeFronzo, R. A. (1992) · Diabetologia · doi:10.1007/bf00401208 · Cited by 430
Metabolic Effects of New Oral Hypoglycemic Agent CS-045 in NIDDM Subjects
Suter, S. L., Nolan, J. J., Wallace, P., Gumbiner, B., & Olefsky, J. M. (1992) · Diabetes Care · doi:10.2337/diacare.15.2.193 · Cited by 420
Gerich, J. E. (1998) · Endocrine Reviews · doi:10.1210/edrv.19.4.0338 · Cited by 420
Accumulation of Metformin by Tissues of the Normal and Diabetic Mouse
Wilcock, C., & Bailey, C. J. (1994) · Xenobiotica · doi:10.3109/00498259409043220 · Cited by 418
Mechanism of metformin action in obese and lean noninsulin-dependent diabetic subjects
DEFRONZO, R. A., BARZILAI, N., & SIMONSON, D. C. (1991) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem-73-6-1294 · Cited by 408
Lactic Acidosis in Patients with Diabetes Treated with Metformin
Misbin, R. I., Green, L., Stadel, B. V., Gueriguian, J. L., Gubbi, A., & Fleming, G. A. (1998) · New England Journal of Medicine · doi:10.1056/nejm199801223380415 · Cited by 403
Terauchi, Y., Tsuji, Y., Satoh, S., Minoura, H., Murakami, K., Okuno, A., Inukai, K., Asano, T., Kaburagi, Y., Ueki, K., et al. (1999) · Nature Genetics · doi:10.1038/6023 · Cited by 399
Bogardus, C., Lillioja, S., Howard, B. V., Reaven, G., & Mott, D. (1984) · Journal of Clinical Investigation · doi:10.1172/jci111533 · Cited by 397
Dunn, C. J., & Peters, D. H. (1995) · Drugs · doi:10.2165/00003495-199549050-00007 · Cited by 391
Hofmann, C. (1994) · Endocrinology · doi:10.1210/en.134.1.264 · Cited by 387
Body fat and sympathetic nerve activity in healthy subjects.
Scherrer, U., Randin, D., Tappy, L., Vollenweider, P., Jéquier, E., & Nicod, P. (1994) · Circulation · doi:10.1161/01.cir.89.6.2634 · Cited by 383
Lavan, B. E., Fantin, V. R., Chang, E. T., Lane, W. S., Keller, S. R., & Lienhard, G. E. (1997) · Journal of Biological Chemistry · doi:10.1074/jbc.272.34.21403 · Cited by 380
Kieffer, T. J., Heller, R. S., Leech, C. A., Holz, G. G., & Habener, J. F. (1997) · Diabetes · doi:10.2337/diab.46.6.1087 · Cited by 380
A genome-wide scan for human obesity genes reveals a major susceptibility locus on chromosome 10
Hager, J., Dina, C., Francke, S., Dubois, S., Houari, M., Vatin, V., Vaillant, E., Lorentz, N., Basdevant, A., Clement, K., et al. (1998) · Nature Genetics · doi:10.1038/3123 · Cited by 369
Cardiac and Glycemic Benefits of Troglitazone Treatment in NIDDM
Ghazzi, M. N., Perez, J. E., Antonucci, T. K., Driscoll, J. H., Huang, S. M., Faja, B. W., The Troglitazone Study Group, & Whitcomb, R. W. (1997) · Diabetes · doi:10.2337/diab.46.3.433 · Cited by 366
Kotani, K., Ogawa, W., Matsumoto, M., Kitamura, T., Sakaue, H., Hino, Y., Miyake, K., Sano, W., Akimoto, K., Ohno, S., et al. (1998) · Molecular and Cellular Biology · doi:10.1128/mcb.18.12.6971 · Cited by 360
Björnholm, M., Kawano, Y., Lehtihet, M., & Zierath, J. R. (1997) · Diabetes · doi:10.2337/diab.46.3.524 · Cited by 359
De Vos, P., Lefebvre, A. M., Miller, S. G., Guerre-Millo, M., Wong, K., Saladin, R., Hamann, L. G., Staels, B., Briggs, M. R., & Auwerx, J. (1996) · Journal of Clinical Investigation · doi:10.1172/jci118860 · Cited by 357
Obesity and insulin resistance in humans: A dose-response study
Bonadonna, R. C., Leif, G., Kraemer, N., Ferrannini, E., Prato, S. D., & DeFronzo, R. A. (1990) · Metabolism · doi:10.1016/0026-0495(90)90002-t · Cited by 355
Nagi, D. K., & Yudkin, J. S. (1993) · Diabetes Care · doi:10.2337/diacare.16.4.621 · Cited by 353
Lavan, B. E., Lane, W. S., & Lienhard, G. E. (1997) · Journal of Biological Chemistry · doi:10.1074/jbc.272.17.11439 · Cited by 349
Hermann, L. S., Scherstén, B., Bitzén, P.-O., Kjellström, T., Lindgärde, F., & Melander, A. (1994) · Diabetes Care · doi:10.2337/diacare.17.10.1100 · Cited by 344
Taylor, S. I. (1992) · Diabetes · doi:10.2337/diab.41.11.1473 · Cited by 344
Caro, J. F., Sinha, M. K., Raju, S. M., Ittoop, O., Pories, W. J., Flickinger, E. G., Meelheim, D., & Dohm, G. L. (1987) · Journal of Clinical Investigation · doi:10.1172/jci112958 · Cited by 341
Beck-Nielsen, H., & Groop, L. C. (1994) · Journal of Clinical Investigation · doi:10.1172/jci117518 · Cited by 339
Antidiabetic thiazolidinediones inhibit leptin (ob) gene expression in 3T3-L1 adipocytes.
Kallen, C. B., & Lazar, M. A. (1996) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.93.12.5793 · Cited by 337
Troglitazone action is independent of adipose tissue.
Burant, C. F., Sreenan, S., Hirano, K., Tai, T. A., Lohmiller, J., Lukens, J., Davidson, N. O., Ross, S., & Graves, R. A. (1997) · Journal of Clinical Investigation · doi:10.1172/jci119839 · Cited by 334
Effect of Troglitazone in Insulin-Treated Patients with Type II Diabetes Mellitus
Schwartz, S., Raskin, P., Fonseca, V., & Graveline, J. F. (1998) · New England Journal of Medicine · doi:10.1056/nejm199803263381302 · Cited by 331
Cohen, N., Halberstam, M., Shlimovich, P., Chang, C. J., Shamoon, H., & Rossetti, L. (1995) · Journal of Clinical Investigation · doi:10.1172/jci117951 · Cited by 327
Aminoacid polymorphisms of insulin receptor substrate-1 in non-insulin-dependent diabetes mellitus
Almind, K., Bjørbaek, C., Vestergaard, H., Hansen, T., Echwald, S., & Pedersen, O. (1993) · The Lancet · doi:10.1016/0140-6736(93)92694-o · Cited by 325
Mahtani, M. M., Widén, E., Lehto, M., Thomas, J., McCarthy, M., Brayer, J., Bryant, B., Chan, G., Daly, M., Forsblom, C., et al. (1996) · Nature Genetics · doi:10.1038/ng0996-90 · Cited by 323
Diamanti-Kandarakis, E., Kouli, C., Tsianateli, T., & Bergiele, A. (1998) · European Journal of Endocrinology · doi:10.1530/eje.0.1380269 · Cited by 323
Lee, A., & Morley, J. E. (1998) · Obesity Research · doi:10.1002/j.1550-8528.1998.tb00314.x · Cited by 320
Skeletal muscle glycolysis, oxidation, and storage of an oral glucose load.
Kelley, D., Mitrakou, A., Marsh, H., Schwenk, F., Benn, J., Sonnenberg, G., Arcangeli, M., Aoki, T., Sorensen, J., & Berger, M. (1988) · Journal of Clinical Investigation · doi:10.1172/jci113489 · Cited by 320
Contribution of Abnormal Muscle and Liver Glucose Metabolism to Postprandial Hyperglycemia in NIDDM
Mitrakou, A., Kelley, D., Veneman, T., Jenssen, T., Pangburn, T., Reilly, J., & Gerich, J. (1990) · Diabetes · doi:10.2337/diab.39.11.1381 · Cited by 317
Mäkimattila, S., Nikkilä, K., & Yki-Järvinen, H. (1999) · Diabetologia · doi:10.1007/s001250051172 · Cited by 314
Insulin-Stimulated Akt Kinase Activity Is Reduced in Skeletal Muscle From NIDDM Subjects
Krook, A., Roth, R. A., Jiang, X. J., Zierath, J. R., & Wallberg-Henriksson, H. (1998) · Diabetes · doi:10.2337/diab.47.8.1281 · Cited by 310
Pioglitazone Induces In Vivo Adipocyte Differentiation in the Obese Zucker fa/fa Rat
Haliakon, S., Doaré, L., Foufelle, F., Kergoat, M., Guerre-Millo, M., Berthault, M.-F., Dugail, I., Morin, J., Auwerx, J., & Ferré, P. (1997) · Diabetes · doi:10.2337/diab.46.9.1393 · Cited by 306
A genome-wide search for type 2 diabetes susceptibility genes in Utah Caucasians.
Elbein, S. C., Hoffman, M. D., Teng, K., Leppert, M. F., & Hasstedt, S. J. (1999) · Diabetes · doi:10.2337/diabetes.48.5.1175 · Cited by 304
Abnormal renal and hepatic glucose metabolism in type 2 diabetes mellitus.
Meyer, C., Stumvoll, M., Nadkarni, V, Dostou, J., Mitrakou, A., & Gerich, J. (1998) · Journal of Clinical Investigation · doi:10.1172/jci2415 · Cited by 300
Self-citationAcarbose: An Update of its Pharmacology and Therapeutic Use in Diabetes Mellitus
Balfour, J. A., & McTavish, D. (1993) · Drugs · doi:10.2165/00003495-199346060-00007 · Cited by 300
Gimble, J. M., Robinson, C. E., Wu, X., Kelly, K. A., Rodriguez, B. R., Kliewer, S. A., Lehmann, J. M., & Morris, D. C. (1996) · Molecular Pharmacology · doi:10.1016/s0026-895x(25)09536-7 · Cited by 295
TNF-α and insulin resistance: Summary and future prospects
Peraldi, P., & Spiegelman, B. (1998) · Molecular and Cellular Biochemistry · doi:10.1023/a:1006865715292 · Cited by 286
Fujita, T., Sugiyama, Y., Taketomi, S., Sohda, T., Kawamatsu, Y., Iwatsuka, H., & Suzuoki, Z. (1983) · Diabetes · doi:10.2337/diab.32.9.804 · Cited by 286
Maggs, D. G., Buchanan, T. A., Burant, C. F., Cline, G., Gumbiner, B., Hsueh, W. A., Inzucchi, S., Kelley, D., Nolan, J., Olefsky, J. M., et al. (1998) · Annals of Internal Medicine · doi:10.7326/0003-4819-128-3-199802010-00002 · Cited by 286
Effects of subcutaneous glucagon-like peptide 1 (GLP-1 [7-36 amide]) in patients with NIDDM
Nauck, M. A., Wollschläger, D., Werner, J., Holst, J. J., Ørskov, C., Creutzfeldt, W., & Willms, B. (1996) · Diabetologia · doi:10.1007/s001250050613 · Cited by 285
Clissold, S. P., & Edwards, C. (1988) · Drugs · doi:10.2165/00003495-198835030-00003 · Cited by 282
Carbohydrate Metabolism in Non-Insulin-Dependent Diabetes Mellitus
Dinneen, S., Gerich, J., & Rizza, R. (1992) · New England Journal of Medicine · doi:10.1056/nejm199209033271007 · Cited by 279
Seufert, J., Kieffer, T. J., Leech, C. A., Holz, G. G., Moritz, W., Ricordi, C., & Habener, J. F. (1999) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.84.2.5460 · Cited by 278
Insulin resistance and lipid metabolism
Howard, B. V. (1999) · The American Journal of Cardiology · doi:10.1016/s0002-9149(99)00355-0 · Cited by 261
Effect of Metformin on Carbohydrate and Lipoprotein Metabolism in NIDDM Patients
Wu, M.-S., Johnston, P., Sheu, W.-H., Hollenbeck, C., Jeng, C.-Y., Goldfine, I., Chen, Y.-D., & Reaven, G. (1990) · Diabetes Care · doi:10.2337/diacare.13.1.1 · Cited by 257
Renal glucose production and utilization: new aspects in humans
Stumvoll, M., Meyer, C., Mitrakou, A., Nadkarni, V., & Gerich, J. E. (1997) · Diabetologia · doi:10.1007/s001250050745 · Cited by 257
Self-citationEffect of insulin on the distribution and disposition of glucose in man.
Ferrannini, E., Smith, J. D., Cobelli, C., Toffolo, G., Pilo, A., & DeFronzo, R. A. (1985) · Journal of Clinical Investigation · doi:10.1172/jci111969 · Cited by 254
An Overview of Metformin in the Treatment of Type 2 Diabetes Mellitus
Davidson, M. B., & Peters, A. L. (1997) · The American Journal of Medicine · doi:10.1016/s0002-9343(96)00353-1 · Cited by 250
Troglitazone Lowers Islet Fat and Restores Beta Cell Function of Zucker Diabetic Fatty Rats
Shimabukuro, M., Zhou, Y.-T., Lee, Y., & Unger, R. H. (1998) · Journal of Biological Chemistry · doi:10.1074/jbc.273.6.3547 · Cited by 249
Cellular Mechanism of Action of Metformin
Klip, A., & Leiter, L. A. (1990) · Diabetes Care · doi:10.2337/diacare.13.6.696 · Cited by 237
Leptin inhibits insulin secretion by activation of phosphodiesterase 3B.
Zhao, A. Z., Bornfeldt, K. E., & Beavo, J. A. (1998) · Journal of Clinical Investigation · doi:10.1172/jci3920 · Cited by 236
Troglitazone, an insulin action enhancer, improves metabolic control in NIDDM patients
The Troglitazone study group, Kumar, S., Boulton, A. J. M., Beck-Nielsen, H., Berthezene, F., Muggeo, M., Persson, B., Spinas, G. A., Donoghue, S., Lettis, S., et al. (1996) · Diabetologia · doi:10.1007/bf00418542 · Cited by 236
Freidenberg, G. R., Henry, R. R., Klein, H. H., Reichart, D. R., & Olefsky, J. M. (1987) · Journal of Clinical Investigation · doi:10.1172/jci112789 · Cited by 234
Thiazolidinediones and Fatty Acids Convert Myogenic Cells into Adipose-like Cells
Teboul, L., Gaillard, D., Staccini, L., Inadera, H., Amri, E.-Z., & Grimaldi, P. A. (1995) · Journal of Biological Chemistry · doi:10.1074/jbc.270.47.28183 · Cited by 231
Almind, K., Inoue, G., Pedersen, O., & Kahn, C. R. (1996) · Journal of Clinical Investigation · doi:10.1172/jci118705 · Cited by 231
Two Cases of Severe Clinical and Histologic Hepatotoxicity Associated with Troglitazone
Gitlin, N., Julie, N. L., Spurr, C. L., Lim, K. N., & Juarbe, H. M. (1998) · Annals of Internal Medicine · doi:10.7326/0003-4819-129-1-199807010-00008 · Cited by 230
Henry, R. R., Gumbiner, B., Ditzler, T., Wallace, P., Lyon, R., & Glauber, H. S. (1993) · Diabetes Care · doi:10.2337/diacare.16.1.21 · Cited by 227
Perriello, G., Misericordia, P., Volpi, E., Santucci, A., Santucci, C., Ferrannini, E., Ventura, M. M., Santeusanio, F., Brunetti, P., & Bolli, G. B. (1994) · Diabetes · doi:10.2337/diab.43.7.920 · Cited by 227
Pathogenesis of non-insulin-dependent diabetes mellitus
Yki-Järvinen, H. (1994) · The Lancet · doi:10.1016/s0140-6736(94)90821-4 · Cited by 227
Campbell, P. J., Mandarino, L. J., & Gerich, J. E. (1988) · Metabolism · doi:10.1016/0026-0495(88)90023-6 · Cited by 226
LANDIN, K., TENGBORN, L., & SMITH, U. (1991) · Journal of Internal Medicine · doi:10.1111/j.1365-2796.1991.tb00328.x · Cited by 225
Avilés-Santa, L., Sinding, J., & Raskin, P. (1999) · Annals of Internal Medicine · doi:10.7326/0003-4819-131-3-199908030-00004 · Cited by 225
Type 2 diabetes: Evidence for linkage on chromosome 20 in 716 Finnish affected sib pairs
Ghosh, S., Watanabe, R. M., Hauser, E. R., Valle, T., Magnuson, V. L., Erdos, M. R., Langefeld, C. D., Balow, J., Ally, D. S., Kohtamaki, K., et al. (1999) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.96.5.2198 · Cited by 224
Goldfine, A. B. (1995) · Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.80.11.3311 · Cited by 223
Dunaif, A. (1996) · Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.81.9.3299 · Cited by 223
Kroder, G., Bossenmaier, B., Kellerer, M., Capp, E., Stoyanov, B., Mühlhöfer, A., Berti, L., Horikoshi, H., Ullrich, A., & Häring, H. (1996) · Journal of Clinical Investigation · doi:10.1172/jci118569 · Cited by 222
Self-citationYoshioka, T., Fujita, T., Kanai, T., Aizawa, Y., Kurumada, T., Hasegawa, K., & Horikoshi, H. (1989) · Journal of Medicinal Chemistry · doi:10.1021/jm00122a022 · Cited by 221
Cavaghan, M. K., Ehrmann, D. A., Byrne, M. M., & Polonsky, K. S. (1997) · Journal of Clinical Investigation · doi:10.1172/jci119562 · Cited by 216
Insulin Treatment Reverses the Insulin Resistance of Type II Diabetes Mellitus
Scarlett, J. A., Gray, R. S., Griffin, J., Olefsky, J. M., & Kolterman, O. G. (1982) · Diabetes Care · doi:10.2337/diacare.5.4.353 · Cited by 216
The Acute and Chronic Effects of Sulfonylurea Therapy in Type II Diabetic Subjects
Kolterman, O. G., Gray, R. S., Shapiro, G., Scarlett, J. A., Griffin, J., & Olefsky, J. M. (1984) · Diabetes · doi:10.2337/diab.33.4.346 · Cited by 213
Clausen, J. O., Hansen, T., Bjørbaek, C., Echwald, S. M., Urhammer, S. A., Rasmussen, S., Andersen, C. B., Hansen, L., Almind, K., Pedersen, O., et al. (1995) · The Lancet · doi:10.1016/s0140-6736(95)92779-4 · Cited by 213
GENETICS OF NON-INSULIN-DEPENDENT (TYPE-II) DIABETES MELLITUS
Kahn, M. D., Vicent, M. D., & Doria, M. D. (1996) · Annual Review of Medicine · doi:10.1146/annurev.med.47.1.509 · Cited by 213
Bowden, D. W., Sale, M., Howard, T. D., Qadri, A., Spray, B. J., Rothschild, C. B., Akots, G., Rich, S. S., & Freedman, B. I. (1997) · Diabetes · doi:10.2337/diab.46.5.882 · Cited by 212
An autosomal genomic scan for loci linked to prediabetic phenotypes in Pima Indians.
Pratley, R. E., Thompson, D. B., Prochazka, M., Baier, L., Mott, D., Ravussin, E., Sakul, H., Ehm, M. G., Burns, D. K., Foroud, T., et al. (1998) · Journal of Clinical Investigation · doi:10.1172/jci1850 · Cited by 208
Campbell, P. J., Carlson, M. G., Hill, J. O., & Nurjhan, N. (2006) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.2006.263.6.e1063 · Cited by 207
Giugliano, D., De Rosa, N., Di Maro, G., Marfella, R., Acampora, R., Buoninconti, R., & D'Onofrio, F. (1993) · Diabetes Care · doi:10.2337/diacare.16.10.1387 · Cited by 206
Berti, L., Kellerer, M., Capp, E., & H�ring, H. U. (1997) · Diabetologia · doi:10.1007/s001250050722 · Cited by 204
Self-citationBuckingham, R. E., Al-Barazanji, K. A., Toseland, C. D. N., Slaughter, M., Connor, S. C., West, A., Bond, B., Turner, N. C., & Clapham, J. C. (1998) · Diabetes · doi:10.2337/diab.47.8.1326 · Cited by 203
Mechanism of metformin action in non-insulin-dependent diabetes
Jackson, R. A., Hawa, M. I., Jaspan, J. B., Sim, B. M., DiSilvio, L., Featherbe, D., & Kurtz, A. B. (1987) · Diabetes · doi:10.2337/diab.36.5.632 · Cited by 202
Glucose fatty acid interactions and the regulation of glucose disposal
Randle, P. J., Priestman, D. A., Mistry, S. C., & Halsall, A. (1994) · Journal of Cellular Biochemistry · doi:10.1002/jcb.240550002 · Cited by 199
Hepatocellular Injury in a Patient Receiving Rosiglitazone: A Case Report
Al-Salman, J., Arjomand, H., Kemp, D. G., & Mittal, M. (2000) · Annals of Internal Medicine · doi:10.7326/0003-4819-132-2-200001180-00006 · Cited by 196
Troglitazone-Induced Hepatic Failure Leading to Liver Transplantation: A Case Report
Neuschwander-Tetri, B. A., Isley, W. L., Oki, J. C., Ramrakhiani, S., Quiason, S. G., Phillips, N. J., & Brunt, E. M. (1998) · Annals of Internal Medicine · doi:10.7326/0003-4819-129-1-199807010-00009 · Cited by 195
Nurjhan, N., Consoli, A., & Gerich, J. (1992) · Journal of Clinical Investigation · doi:10.1172/jci115558 · Cited by 195
Freidenberg, G. R., Reichart, D., Olefsky, J. M., & Henry, R. R. (1988) · Journal of Clinical Investigation · doi:10.1172/jci113744 · Cited by 195
Andrews, W. J., Vasquez, B., Nagulesparan, M., Klimes, I., Foley, J., Unger, R., & Reaven, G. M. (1984) · Diabetes · doi:10.2337/diab.33.7.634 · Cited by 194
Effect of Physical Training on Insulin Action in Obesity
DeFronzo, R. A., Sherwin, R. S., & Kraemer, N. (1987) · Diabetes · doi:10.2337/diab.36.12.1379 · Cited by 189
Oral Vanadyl Sulfate Improves Insulin Sensitivity in NIDDM but Not in Obese Nondiabetic Subjects
Halberstam, M., Cohen, N., Shlimovich, P., Rossetti, L., & Shamoon, H. (1996) · Diabetes · doi:10.2337/diab.45.5.659 · Cited by 187
Efficacy of metformin in the treatment of NIDDM. Meta-analysis.
Johansen, K. (1999) · Diabetes Care · doi:10.2337/diacare.22.1.33 · Cited by 186
Role of Metformin Accumulation in Metformin-Associated Lactic Acidosis
Lalau, J. D., Lacroix, C., Compagnon, P., Cagny, B. D., Rigaud, J. P., Bleichner, G., Chauveau, P., Dulbecco, P., Guérin, C., Haegy, J. M., et al. (1995) · Diabetes Care · doi:10.2337/diacare.18.6.779 · Cited by 185
Chiasson, J.-L., Gomis, R., Hanefeld, M., Josse, R. G., Karasik, A., Laakso, M., & The Stop-Niddm Trial Research Group (1998) · Diabetes Care · doi:10.2337/diacare.21.10.1720 · Cited by 182
Patel, J., Anderson, R. J., & Rappaport, E. B. (1999) · Diabetes, Obesity and Metabolism · doi:10.1046/j.1463-1326.1999.00020.x · Cited by 181
Coniff, R. F., Shapiro, J. A., Seaton, T. B., & Bray, G. A. (1995) · The American Journal of Medicine · doi:10.1016/s0002-9343(99)80343-x · Cited by 180
Vanadate normalizes hyperglycemia in two mouse models of non-insulin-dependent diabetes mellitus.
Meyerovitch, J., Rothenberg, P., Shechter, Y., Bonner-Weir, S., & Kahn, C. R. (1991) · Journal of Clinical Investigation · doi:10.1172/jci115131 · Cited by 177
Hanefeld, M., Fischer, S., Schulze, J., Spengler, M., Wargenau, M., Schollberg, K., & Fücker, K. (1991) · Diabetes Care · doi:10.2337/diacare.14.8.732 · Cited by 176
Rationale and Application of Fatty Acid Oxidation Inhibitors in Treatment of Diabetes Mellitus
Foley, J. E. (1992) · Diabetes Care · doi:10.2337/diacare.15.6.773 · Cited by 174
Grant, P. J. (1996) · Diabetes Care · doi:10.2337/diacare.19.1.64 · Cited by 173
Giugliano, D., Quatraro, A., Consoli, G., Minei, A., Ceriello, A., De Rosa, N., & D'Onofrio, F. (1993) · European Journal of Clinical Pharmacology · doi:10.1007/bf00315466 · Cited by 169
The Effect of Acarbose on Insulin Sensitivity in Subjects With Impaired Glucose Tolerance
Chiasson, J.-L., Josse, R. G., Leiter, L. A., Mihic, M., Nathan, D. M., Palmason, C., Cohen, R. M., & Wolever, T. M. (1996) · Diabetes Care · doi:10.2337/diacare.19.11.1190 · Cited by 169
Tafuri, S. R. (1996) · Endocrinology · doi:10.1210/en.137.11.4706 · Cited by 168
Nurjhan, N., Campbell, P. J., Kennedy, F. P., Miles, J. M., & Gerich, J. E. (1986) · Diabetes · doi:10.2337/diab.35.12.1326 · Cited by 168
Bradykinin directly triggers GLUT4 translocation via an insulin-independent pathway.
Kishi, K., Muromoto, N., Nakaya, Y., Miyata, I., Hagi, A., Hayashi, H., & Ebina, Y. (1998) · Diabetes · doi:10.2337/diabetes.47.4.550 · Cited by 167
Mechanisms of the Glycaemic Effects of Sulfonylureas
Ashcroft, F. (1996) · Hormone and Metabolic Research · doi:10.1055/s-2007-979837 · Cited by 166
Mechanism of improvement in glucose metabolism after chronic glyburide therapy
Simonson, D. C., Ferrannini, E., Bevilacqua, S., Smith, D., Barrett, E., Carlson, R., & DeFronzo, R. A. (1984) · Diabetes · doi:10.2337/diabetes.33.9.838 · Cited by 166
Cited by
Association between insulin resistance and the development of cardiovascular disease
Ormazabal, V., Nair, S., Elfeky, O., Aguayo, C., Salomon, C., & Zuñiga, F. A. (2018) · Cardiovascular Diabetology · doi:10.1186/s12933-018-0762-4 · Cited by 2,280
Cho, H., Mu, J., Kim, J. K., Thorvaldsen, J. L., Chu, Q., Crenshaw, E. B., Kaestner, K. H., Bartolomei, M. S., Shulman, G. I., & Birnbaum, M. J. (2001) · Science · doi:10.1126/science.292.5522.1728 · Cited by 1,836
Trends in insulin resistance: insights into mechanisms and therapeutic strategy
Li, M., Chi, X., Wang, Y., Setrerrahmane, S., Xie, W., & Xu, H. (2022) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-022-01073-0 · Cited by 939
Transcriptional Regulation of Metabolism
Desvergne, B., Michalik, L., & Wahli, W. (2006) · Physiological Reviews · doi:10.1152/physrev.00025.2005 · Cited by 892
Er, L.-K., Wu, S., Chou, H.-H., Hsu, L.-A., Teng, M.-S., Sun, Y.-C., & Ko, Y.-L. (2016) · PLOS ONE · doi:10.1371/journal.pone.0149731 · Cited by 708
Metadata
- Authors
- Matthaei, S., Stumvoll, M., Kellerer, M., & Häring, H.-U.
- Venue
- Endocrine Reviews
- Publisher
- The Endocrine Society
- Published
- 2000-12-01
- Volume
- 21
- Issue
- 6
- Pages
- 585-618
- ISSN
- 0163-769X (ISSN-L)
- 1945-7189
- OpenAlex
- W2011419421
- Cited by
- 377
- References
- 428
- FWCI
- 11.31
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.